Sintx Technologies (SINT) Competitors $4.03 -0.30 (-6.93%) Closing price 09/16/2025 04:00 PM EasternExtended Trading$4.03 0.00 (-0.02%) As of 09/16/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SINT vs. GUTS, PSTV, WOK, NMTC, ZYXI, NEPH, MODD, TMDIF, ECOR, and RBOTShould you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include Fractyl Health (GUTS), Plus Therapeutics (PSTV), WORK Medical Technology Group (WOK), NeuroOne Medical Technologies (NMTC), Zynex (ZYXI), Nephros (NEPH), Modular Medical (MODD), Titan Medical (TMDIF), electroCore (ECOR), and Vicarious Surgical (RBOT). These companies are all part of the "medical equipment" industry. Sintx Technologies vs. Its Competitors Fractyl Health Plus Therapeutics WORK Medical Technology Group NeuroOne Medical Technologies Zynex Nephros Modular Medical Titan Medical electroCore Vicarious Surgical Sintx Technologies (NASDAQ:SINT) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, analyst recommendations, earnings, profitability, dividends and valuation. Which has preferable earnings and valuation, SINT or GUTS? Sintx Technologies has higher revenue and earnings than Fractyl Health. Fractyl Health is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSintx Technologies$2.89M3.85-$11.02M-$50.56-0.08Fractyl Health$90K555.87-$68.69M-$2.06-0.48 Does the media prefer SINT or GUTS? In the previous week, Fractyl Health had 4 more articles in the media than Sintx Technologies. MarketBeat recorded 5 mentions for Fractyl Health and 1 mentions for Sintx Technologies. Fractyl Health's average media sentiment score of 0.87 beat Sintx Technologies' score of 0.64 indicating that Fractyl Health is being referred to more favorably in the news media. Company Overall Sentiment Sintx Technologies Positive Fractyl Health Positive Do analysts recommend SINT or GUTS? Sintx Technologies currently has a consensus target price of $28.00, suggesting a potential upside of 594.79%. Fractyl Health has a consensus target price of $7.15, suggesting a potential upside of 618.74%. Given Fractyl Health's higher possible upside, analysts clearly believe Fractyl Health is more favorable than Sintx Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sintx Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Fractyl Health 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders have more ownership in SINT or GUTS? 18.4% of Sintx Technologies shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Comparatively, 26.1% of Fractyl Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is SINT or GUTS more profitable? Sintx Technologies has a net margin of -674.05% compared to Fractyl Health's net margin of -73,864.52%. Sintx Technologies' return on equity of -256.59% beat Fractyl Health's return on equity.Company Net Margins Return on Equity Return on Assets Sintx Technologies-674.05% -256.59% -121.32% Fractyl Health -73,864.52%-584.35%-102.88% Which has more volatility & risk, SINT or GUTS? Sintx Technologies has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, Fractyl Health has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500. SummaryFractyl Health beats Sintx Technologies on 9 of the 15 factors compared between the two stocks. Get Sintx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SINT vs. The Competition Export to ExcelMetricSintx TechnologiesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.95M$6.74B$5.73B$10.31BDividend YieldN/A1.21%5.90%4.63%P/E Ratio-0.0826.6075.8626.51Price / Sales3.85194.74528.72123.58Price / CashN/A21.6137.1760.46Price / Book1.394.9412.796.29Net Income-$11.02M$176.38M$3.28B$270.51M7 Day Performance-7.57%5.78%0.81%1.95%1 Month Performance32.57%7.07%4.60%6.33%1 Year Performance7.47%16.37%70.39%25.62% Sintx Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SINTSintx Technologies1.8793 of 5 stars$4.03-6.9%$28.00+594.8%+10.4%$11.95M$2.89M-0.0840GUTSFractyl Health2.5867 of 5 stars$0.94+1.6%$6.53+592.1%-62.3%$47.63M$90K-0.46102News CoverageAnalyst ForecastPSTVPlus Therapeutics3.2026 of 5 stars$0.46-3.3%$7.88+1,604.5%-71.5%$46.55M$5.82M-0.2120Short Interest ↑WOKWORK Medical Technology GroupN/A$0.79+1.3%N/A-81.4%$45.20M$11.51M0.00226Positive NewsNMTCNeuroOne Medical Technologies2.6545 of 5 stars$0.89+5.2%$1.45+62.2%+9.7%$44.75M$3.45M-5.9720ZYXIZynex2.334 of 5 stars$1.46flat$4.90+235.6%-80.4%$44.54M$192.35M-1.56770NEPHNephros3.231 of 5 stars$4.26+8.4%$5.50+29.1%+139.4%$44.47M$14.16M34.9630Short Interest ↓MODDModular Medical1.2479 of 5 stars$0.73+1.4%N/A-69.2%$40.35MN/A-1.4320Gap DownTMDIFTitan MedicalN/A$0.34+2.7%N/A+846.2%$38.38M$17.63M-0.2750ECORelectroCore2.2389 of 5 stars$4.94+0.3%$25.50+416.7%-20.9%$37.41M$25.18M-3.0550RBOTVicarious Surgical1.6983 of 5 stars$6.15-1.4%$7.00+13.9%+3.2%$36.17MN/A-0.60210Negative News Related Companies and Tools Related Companies GUTS Alternatives PSTV Alternatives WOK Alternatives NMTC Alternatives ZYXI Alternatives NEPH Alternatives MODD Alternatives TMDIF Alternatives ECOR Alternatives RBOT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SINT) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sintx Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sintx Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.